{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/01/3304711/0/en/Abivax-Announces-Landmark-Phase-3-ABTECT-Maintenance-Trial-Results-Evaluating-Obefazimod-in-Moderately-to-Severely-Active-Ulcerative-Colitis.html", "message": "News view counter 771177 successfully enlarged"}